Home NDC 55700-191 Triamterene and Hydrochlorothiazide
Product NDC 55700-191
11-digit product format 557000191
Labeler code 55700
Product ID 55700-191_01cb895f-0d3f-4fac-8aa2-2a60366fa855
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Triamterene and Hydrochlorothiazide
Dosage form TABLET
Route ORAL
Labeler Lake Erie Medical DBA Quality Care Products LLC
Application NDA019129
Marketing category NDA
Marketing start 1996-09-16
Marketing end 0000-00-00
Substance TRIAMTERENE; HYDROCHLOROTHIAZIDE
Active strength 38 mg/1; mg/1
Pharmacologic classes Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag No
Listing certified through 2019-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 48 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N019129-001 MAXZIDE HYDROCHLOROTHIAZIDE; TRIAMTERENE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 N019129-003 MAXZIDE-25 HYDROCHLOROTHIAZIDE; TRIAMTERENE 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 84e616aacf4f…2026-08-18 06:07:40 2026-07 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 74a2ff9319b5…
Observed Orange Book normalized TE history# Normalized TE history page 3 of 3 · 86 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.